Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Thyroid cancer in youth raises future cancer risk. Children and young adults who survived differentiated thyroid cancer were 1.5 times more likely to develop a second cancer than peers without a cancer history. The risk climbed even higher for those who received radioactive iodine therapy, pointing to a need for long-term cancer surveillance in this population.
A new study published in Thyroid found that children and young adults who survived differentiated thyroid cancer face a significantly higher risk of developing a second cancer compared to those with no cancer history. Researchers analyzed data from over 5,200 thyroid cancer patients (median age 31.4 years) matched against 21,000+ controls, finding that thyroid cancer survivors had a 50% higher overall risk of future malignancies — and that risk was even steeper for those treated with radioactive iodine (RAI).
The findings held across both sexes and all socioeconomic groups, with second cancers appearing earlier in thyroid cancer survivors (13.8 years vs. 15.1 years post-diagnosis). Survivors who received two or more RAI doses faced nearly triple the risk of a second cancer compared to those who received none.
By the Numbers:
Why it matters: These findings underscore the need for prolonged, structured survivorship programs for young thyroid cancer patients — especially those treated with RAI — as second cancers can emerge decades after the initial diagnosis.
